U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111546) titled 'A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]' on Aug. 01.

Brief Summary: An open-label, multicenter, phase II clinical study to evaluate the efficacy and safety of LBL-024 in combination with other drugs for the treatment of patients with advanced solid tumour.

Study Start Date: Sept. 26

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumour

Intervention: DRUG: LBL-024 for Injection

Intravenous infusion.

DRUG: Durvalumab Injection

Intravenous infusion.

DRUG: Cisplatin Injection

Intravenous infusion.

DRUG: Gemcitabine Hydrochloride for Injection

Intravenou...